Stay updated with breaking news from Johnm Evans. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) was the recipient of a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 14,320,000 shares, an increase of 9.2% from the February 29th total of 13,110,000 shares. Based on an average daily volume of 1,420,000 shares, […]
Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) saw a large increase in short interest in March. As of March 15th, there was short interest totalling 14,320,000 shares, an increase of 9.2% from the February 29th total of 13,110,000 shares. Based on an average daily volume of 1,420,000 shares, the short-interest ratio is presently 10.1 […]
Shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) have earned an average recommendation of “Hold” from the thirteen research firms that are presently covering the company, Marketbeat Ratings reports. Eight equities research analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average […]
Beam Therapeutics (NASDAQ:BEAM – Get Free Report) posted its quarterly earnings data on Tuesday. The company reported $1.73 EPS for the quarter, topping the consensus estimate of ($0.69) by $2.42, Briefing.com reports. Beam Therapeutics had a negative return on equity of 16.90% and a negative net margin of 35.09%. The firm had revenue of $316.20 […]
Beam Therapeutics (NASDAQ:BEAM – Get Free Report) announced its earnings results on Tuesday. The company reported $1.73 earnings per share for the quarter, beating the consensus estimate of ($0.69) by $2.42, Briefing.com reports. Beam Therapeutics had a negative return on equity of 16.90% and a negative net margin of 35.09%. The company had revenue of […]